GO:0016874 | ligase activity | 10.2% (5/49) | 4.46 | 3e-06 | 9.7e-05 |
GO:0044281 | small molecule metabolic process | 14.29% (7/49) | 3.49 | 3e-06 | 0.000101 |
GO:0043038 | amino acid activation | 8.16% (4/49) | 5.42 | 2e-06 | 0.000104 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 8.16% (4/49) | 5.42 | 2e-06 | 0.000104 |
GO:0043039 | tRNA aminoacylation | 8.16% (4/49) | 5.42 | 2e-06 | 0.000104 |
GO:0004812 | aminoacyl-tRNA ligase activity | 8.16% (4/49) | 5.42 | 2e-06 | 0.000104 |
GO:0140101 | catalytic activity, acting on a tRNA | 8.16% (4/49) | 4.75 | 1.5e-05 | 0.000395 |
GO:0006399 | tRNA metabolic process | 8.16% (4/49) | 4.56 | 2.4e-05 | 0.000573 |
GO:1901564 | organonitrogen compound metabolic process | 22.45% (11/49) | 2.05 | 5e-05 | 0.001053 |
GO:0034660 | ncRNA metabolic process | 8.16% (4/49) | 4.09 | 8.9e-05 | 0.001513 |
GO:0006520 | amino acid metabolic process | 8.16% (4/49) | 4.05 | 0.0001 | 0.001569 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.12% (3/49) | 5.13 | 8.5e-05 | 0.001607 |
GO:0034641 | cellular nitrogen compound metabolic process | 16.33% (8/49) | 2.29 | 0.000202 | 0.002924 |
GO:0140098 | catalytic activity, acting on RNA | 8.16% (4/49) | 3.64 | 0.000294 | 0.003457 |
GO:0097159 | organic cyclic compound binding | 28.57% (14/49) | 1.48 | 0.000293 | 0.003669 |
GO:1901363 | heterocyclic compound binding | 28.57% (14/49) | 1.48 | 0.000293 | 0.003669 |
GO:0044238 | primary metabolic process | 26.53% (13/49) | 1.54 | 0.000335 | 0.003701 |
GO:0044237 | cellular metabolic process | 22.45% (11/49) | 1.71 | 0.000397 | 0.004142 |
GO:0006082 | organic acid metabolic process | 8.16% (4/49) | 3.38 | 0.000581 | 0.00475 |
GO:0005524 | ATP binding | 16.33% (8/49) | 2.1 | 0.000488 | 0.004824 |
GO:0043436 | oxoacid metabolic process | 8.16% (4/49) | 3.39 | 0.000567 | 0.004844 |
GO:0019752 | carboxylic acid metabolic process | 8.16% (4/49) | 3.39 | 0.000567 | 0.004844 |
GO:0032559 | adenyl ribonucleotide binding | 16.33% (8/49) | 2.02 | 0.000689 | 0.004984 |
GO:0006807 | nitrogen compound metabolic process | 22.45% (11/49) | 1.61 | 0.000689 | 0.005178 |
GO:0003674 | molecular_function | 55.1% (27/49) | 0.79 | 0.000669 | 0.005238 |
GO:0071704 | organic substance metabolic process | 26.53% (13/49) | 1.46 | 0.000558 | 0.005242 |
GO:0043168 | anion binding | 18.37% (9/49) | 1.82 | 0.000859 | 0.005386 |
GO:0006139 | nucleobase-containing compound metabolic process | 12.24% (6/49) | 2.42 | 0.00085 | 0.005509 |
GO:1901265 | nucleoside phosphate binding | 18.37% (9/49) | 1.82 | 0.00083 | 0.005571 |
GO:0000166 | nucleotide binding | 18.37% (9/49) | 1.82 | 0.00083 | 0.005571 |
GO:0030554 | adenyl nucleotide binding | 16.33% (8/49) | 1.93 | 0.00104 | 0.006306 |
GO:0036094 | small molecule binding | 18.37% (9/49) | 1.75 | 0.001161 | 0.006819 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 8.16% (4/49) | 3.09 | 0.001233 | 0.007023 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.33% (8/49) | 1.88 | 0.001315 | 0.00727 |
GO:0008152 | metabolic process | 26.53% (13/49) | 1.33 | 0.001355 | 0.007279 |
GO:0046483 | heterocycle metabolic process | 12.24% (6/49) | 2.27 | 0.001439 | 0.007312 |
GO:0006725 | cellular aromatic compound metabolic process | 12.24% (6/49) | 2.27 | 0.001439 | 0.007312 |
GO:0032555 | purine ribonucleotide binding | 16.33% (8/49) | 1.81 | 0.001753 | 0.00845 |
GO:1901360 | organic cyclic compound metabolic process | 12.24% (6/49) | 2.22 | 0.001709 | 0.008456 |
GO:0005488 | binding | 36.73% (18/49) | 1.0 | 0.001815 | 0.008533 |
GO:0032553 | ribonucleotide binding | 16.33% (8/49) | 1.8 | 0.001866 | 0.008556 |
GO:0006164 | purine nucleotide biosynthetic process | 4.08% (2/49) | 4.88 | 0.002102 | 0.009192 |
GO:0097367 | carbohydrate derivative binding | 16.33% (8/49) | 1.77 | 0.002095 | 0.009378 |
GO:0106073 | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 2.04% (1/49) | 8.63 | 0.002523 | 0.009487 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 2.04% (1/49) | 8.63 | 0.002523 | 0.009487 |
GO:0006177 | GMP biosynthetic process | 2.04% (1/49) | 8.63 | 0.002523 | 0.009487 |
GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity | 2.04% (1/49) | 8.63 | 0.002523 | 0.009487 |
GO:0046037 | GMP metabolic process | 2.04% (1/49) | 8.63 | 0.002523 | 0.009487 |
GO:0072522 | purine-containing compound biosynthetic process | 4.08% (2/49) | 4.77 | 0.002424 | 0.010357 |
GO:0017076 | purine nucleotide binding | 16.33% (8/49) | 1.73 | 0.002504 | 0.010463 |
GO:0009165 | nucleotide biosynthetic process | 4.08% (2/49) | 4.63 | 0.002947 | 0.010655 |
GO:1901293 | nucleoside phosphate biosynthetic process | 4.08% (2/49) | 4.63 | 0.002947 | 0.010655 |
GO:0043170 | macromolecule metabolic process | 18.37% (9/49) | 1.52 | 0.003596 | 0.012755 |
GO:0006163 | purine nucleotide metabolic process | 4.08% (2/49) | 4.35 | 0.004354 | 0.015158 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.04% (1/49) | 7.63 | 0.00504 | 0.015282 |
GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 2.04% (1/49) | 7.63 | 0.00504 | 0.015282 |
GO:0016093 | polyprenol metabolic process | 2.04% (1/49) | 7.63 | 0.00504 | 0.015282 |
GO:0019348 | dolichol metabolic process | 2.04% (1/49) | 7.63 | 0.00504 | 0.015282 |
GO:0016070 | RNA metabolic process | 8.16% (4/49) | 2.54 | 0.004863 | 0.016039 |
GO:0072521 | purine-containing compound metabolic process | 4.08% (2/49) | 4.27 | 0.004802 | 0.016123 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4.08% (2/49) | 4.24 | 0.005035 | 0.016319 |
GO:1901566 | organonitrogen compound biosynthetic process | 8.16% (4/49) | 2.55 | 0.0048 | 0.016408 |
GO:0009117 | nucleotide metabolic process | 4.08% (2/49) | 4.11 | 0.006013 | 0.017944 |
GO:1901576 | organic substance biosynthetic process | 10.2% (5/49) | 2.09 | 0.006176 | 0.018143 |
GO:0006753 | nucleoside phosphate metabolic process | 4.08% (2/49) | 4.05 | 0.006533 | 0.018894 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009123 | nucleoside monophosphate metabolic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0006741 | NADP biosynthetic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0003951 | NAD+ kinase activity | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.04% (1/49) | 7.05 | 0.00755 | 0.018926 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 8.16% (4/49) | 2.32 | 0.008287 | 0.0205 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.08% (2/49) | 3.77 | 0.009421 | 0.023002 |
GO:0009058 | biosynthetic process | 10.2% (5/49) | 1.93 | 0.00969 | 0.023356 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 2.04% (1/49) | 6.63 | 0.010055 | 0.023928 |
GO:0006739 | NADP metabolic process | 2.04% (1/49) | 6.31 | 0.012553 | 0.028433 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 2.04% (1/49) | 6.31 | 0.012553 | 0.028433 |
GO:0019363 | pyridine nucleotide biosynthetic process | 2.04% (1/49) | 6.31 | 0.012553 | 0.028433 |
GO:0090407 | organophosphate biosynthetic process | 4.08% (2/49) | 3.56 | 0.012421 | 0.02919 |
GO:0003824 | catalytic activity | 30.61% (15/49) | 0.85 | 0.013368 | 0.029918 |
GO:0090304 | nucleic acid metabolic process | 8.16% (4/49) | 2.06 | 0.015165 | 0.03277 |
GO:0072525 | pyridine-containing compound biosynthetic process | 2.04% (1/49) | 6.05 | 0.015045 | 0.032889 |
GO:0016042 | lipid catabolic process | 2.04% (1/49) | 6.05 | 0.015045 | 0.032889 |
GO:0009987 | cellular process | 22.45% (11/49) | 1.03 | 0.015943 | 0.034061 |
GO:0008150 | biological_process | 30.61% (15/49) | 0.81 | 0.017138 | 0.036202 |
GO:0019362 | pyridine nucleotide metabolic process | 2.04% (1/49) | 5.82 | 0.017531 | 0.036218 |
GO:0046496 | nicotinamide nucleotide metabolic process | 2.04% (1/49) | 5.82 | 0.017531 | 0.036218 |
GO:0043167 | ion binding | 18.37% (9/49) | 1.15 | 0.018074 | 0.036934 |
GO:0071949 | FAD binding | 2.04% (1/49) | 5.63 | 0.020011 | 0.039187 |
GO:0072524 | pyridine-containing compound metabolic process | 2.04% (1/49) | 5.63 | 0.020011 | 0.039187 |
GO:0000049 | tRNA binding | 2.04% (1/49) | 5.63 | 0.020011 | 0.039187 |
GO:1901135 | carbohydrate derivative metabolic process | 4.08% (2/49) | 3.22 | 0.019488 | 0.039395 |
GO:0044249 | cellular biosynthetic process | 8.16% (4/49) | 1.92 | 0.021256 | 0.040777 |
GO:0019637 | organophosphate metabolic process | 4.08% (2/49) | 3.15 | 0.021241 | 0.041169 |
GO:0006066 | alcohol metabolic process | 2.04% (1/49) | 5.46 | 0.022484 | 0.042697 |